Your browser doesn't support javascript.
loading
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach.
Galot, R; Le Tourneau, C; Guigay, J; Licitra, L; Tinhofer, I; Kong, A; Caballero, C; Fortpied, C; Bogaerts, J; Govaerts, A-S; Staelens, D; Raveloarivahy, T; Rodegher, L; Laes, J-F; Saada-Bouzid, E; Machiels, J-P.
Afiliação
  • Galot R; Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Belgium; Institute for Clinical and Experimental Research (POLE MIRO), Université Catholique de Louvain, Brussels, Belgium.
  • Le Tourneau C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, Paris, France; INSERM U900 Research Unit, Saint-Cloud, France; Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France.
  • Guigay J; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Licitra L; Head and Neck Cancer Medical Oncology Department, Fondazione IRCCS "Istituto Nazionale dei Tumori", Milan; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Tinhofer I; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin; Department of Radiooncology and Radiotherapy, Berlin Institute of Health, Berlin, Germany.
  • Kong A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Caballero C; European Organization of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Fortpied C; European Organization of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Bogaerts J; European Organization of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Govaerts AS; European Organization of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Staelens D; European Organization of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Raveloarivahy T; European Organization of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Rodegher L; European Organization of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Laes JF; OncoDNA, Gosselies, Belgium.
  • Saada-Bouzid E; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Machiels JP; Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Belgium; Institute for Clinical and Experimental Research (POLE MIRO), Université Catholique de Louvain, Brussels, Belgium. Electronic address: jean-pascal.machiels@uclouvain.be.
Ann Oncol ; 29(12): 2313-2327, 2018 12 01.
Article em En | MEDLINE | ID: mdl-30307465
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Ano de publicação: 2018 Tipo de documento: Article